Metabolic diseases such as obesity, fatty liver, and insulin resistance are rapidly increasing worldwide, but fundamental ...

In patients with obesity and MASLD but not diabetes, berberine is safe but does not reduce visceral adipose tissue or liver fat.

New research being presented at the European Congress on Obesity (ECO) in Venice, Italy (12-15 May), and published in the International Journal of Obesity, could help explain why type 2 diabetes is ...